Lubosan, Edie L.

HRN: 26-03-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2024
10/16/2024
IV
300mg
Q6
Acute Tonsillopharyngitis Exudative, Left; T/C Peritonsillar Abscess
Waiting Final Action 
10/11/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2024
10/18/2024
IV
1.5 Grams
Q8H
Acute Tonsillopharyngitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: